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Abstract 
Thymosin beta-4 (Tʲ4) is a member of beta-
thymosins, a family of small peptides involved
in polymerization of G-actin, and in many crit-
ical biological processes including apoptosis,
cell  migration,  angiogenesis,  and  fibrosis.
Previous studies in the newborn liver did not
reveal any significant reactivity for Tʲ4 during
the intrauterine life. The aim of the present
study was to investigate by immunohistochem-
istry Tʲ4 expression in the adult normal liver.
Thirty-five human liver samples, including 11
needle liver biopsies and 24 liver specimens
obtained at autopsy, in which no pathological
change was detected at the histological exam-
ination,  were  immunostained  utilizing  an
anti-Tʲ4 commercial antibody. Tʲ4 was detect-
ed in the hepatocytes of all adult normal livers
examined. A zonation of Tʲ4 expression was
evident  in  the  vast  majority  of  cases.
Immunostaining was preferentially detected in
zone 3, while a minor degree of reactivity was
detected in periportal hepatocytes (zone 1). At
higher power, Tʲ4-reactive granules appeared
mainly localized at the biliary pole of hepato-
cytes. In cases with a strong immunostaining,
even perinuclear areas and the sinusoidal pole
of  hepatocytes  appeared  interested  by
immunoreactivity for Tʲ4. The current work
first evidences a strong diffuse expression of
Tʲ4 in the adult human liver, and adds hepato-
cytes to the list of human cells able to synthe-
size  large  amounts  of  Tʲ4  in  adulthood.
Moreover, Tʲ4 should be added to the liver pro-
teins characterized by a zonate expression pat-
tern, in a descending gradient from the termi-
nal vein to the periportal areas of the liver aci-
nus.  Identifying  the  intimate  role  played  by
this peptide intracellularly and extracellularly,
in physiology and in different liver diseases, is
a major challenge for future research focusing
on Tʲ4. 
Introduction
Thymosin beta 4 (Tʲ4) is a member of thy-
mosins,1 a versatile family of small peptides
expressed in most mammalian cells.2 It shows
a high intracellular concentration, in cells able
to rapidly increase their motility, like polymor-
phonuclear  leukocytes,  macrophages3,4 and
mast cells.5 There exist about 15 highly homol-
ogous ʲ-thymosin variants, containing 40 to 44
amino acid residues, that are found not only
inside of cells but also in extracellular fluids,
such  as  blood  serum,6 saliva,7 wound  fluid,8
and lacrimal secretion.9 Among thymosin pep-
tides, Tʲ4 is considered the most abundant in
mammalian  tissues:  its  activity  has  been
mainly correlated with the regulation of actin
polymerization in living cells.10 Tʲ4 is thought
to be also involved in many critical biological
processes  including  angiogenesis,11 wound
healing,12 inflammatory  response13 and  cell
migration.14 Similarly, Tʲ4 activity was impli-
cated  in  differentiation  of  hematopoietic
cells,15 in carcinogenesis,16 in apoptosis,17 and
in blood coagulation.18
Recently, many authors have proposed the
Tʲ4 involvement in the process of determining
fibrosis  in  different  organs.  In  mice  with
ureteral obstruction, Tʲ4 has been shown to
have profibrotic effects, while its metabolite
Ac-SDKP  showed  anti-fibrotic  actions.19 In
human  hepatic  stellate  cells  in  culture,  Tʲ4
showed  antifibrogenic  effects,  mediated  by
upregulation of the expression of hepatocyte
grow factor (HGF) and by downregulation of
the expression of platelet-derived growth fac-
tor-ʲ (PDGF-ʲ) receptor.20 A recent study from
our group carried out on the human newborn
liver did not reveal any significant reactivity
for Tʲ4 in the vast majority of liver cells during
gestation and at birth.21
On the basis of these data, and given the
previously  reported  ability  of  thymosins  to
change  their  expression  pattern  at  different
ages, it seemed of some interest to investigate
by immunohistochemistry the Tʲ4 expression
pattern in the adult liver, in order to shed light
on the role played by liver cells in the synthesis
of this peptide. 
Materials and Methods
The  study  included  archived  paraffin-
embedded liver sections obtained from 35 sub-
jects. The cohort included 11 needle liver biop-
sies, performed on different clinical settings,
in which no sign of liver pathology was detect-
ed at the histological examination, and 24 liver
samples obtained in autopsy patients who died
for different extrahepatic aetiologies, in which
careful macroscopic and histological examina-
tion of liver sections did not evidence any sig-
nificant pathological change. The age of sub-
jects (24 males and 11 females) ranged from
29 up to 77 years. Clinical data at the basis of
the decision of performing liver biopsies are
reported in Table 1; the cause of death of the
24 autopsy cases is reported in Table 2. All liver
samples  were  routinely  formalin-fixed  and
paraffin-embedded. 
Staining of formalin-fixed, paraffin-embed-
ded  5  ʼm  sections  for  Tʲ4  was  performed
essentially  as  previously  described.5 Briefly,
slides  were  deparaffinized,  rehydrated,  and
endogenous peroxidase activity was quenced
(30  min)  by  0.3%  hydrogen  peroxide  in
methanol. Slides were then subjected to anti-
gen retrival by boiling (20 min) in 10 mM cit-
rate buffer, pH 6. Slides were incubated with
10%  normal  goat  serum  in  phosphate
buffered saline (PBS) for 60 min to block non-
specific binding, followed by incubation (20 h,
4°C)  with  polyclonal  anti-thymosin  beta  4
antibody (Bachem-Peninsula Lab, San Carlos,
CA, USA) diluted 1:100 in blocking solution.
Slides were extensively washed with PBS con-
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taining  0.01%  Triton  X-100  and  incubated
with  a  secondary  reagent  (Envision  kit)
according  to  the  manufacturer’s  (Dako,
Glostrup, Denmark) instructions. After addi-
tional washes, color was developed using AEC
reagent  (Dako),  sections  were  counter-
stained  with  hematoxylin  and  mounted.
Immunostained specimens were examined by
two pathologists (GF, SN). A semiquantitative
grading  system  for  the  evaluation  of  Tʲ4
immunoreactivity has been applied: + = focal
weak staining; ++ = diffuse weak staining;
+++  =  diffuse  strong  staining.  Zone  3
(periterminal hepatocytes) and zone 1 (peri-
portal hepatocytes) were independently ana-
lyzed for Tʲ4 immunoreactivity.
Results
Tʲ4  reactivity  was  detected  in  all  normal
liver biopsies of adult subjects studied. No sig-
nificant  difference  was  observed  between
bioptic and autoptic liver examined. No rela-
tionship was found between the degree of Tʲ4
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Table 1. clincal and immunohistochemical data of 11 liver needle biopsies characterized at histology by absent or minimal changes. 
+ = weak and focal; ++ = weak and diffuse; +++ = strong and diffuse.
Case n.  Age Sex Clinical diagnosis Grade of Tß4 immunostaining Zone 3 Grade of Tß4 immunostaining Zone 1
1 40 M HCV  +-
2 36 M HBV + HCV +-
3 67 F HBV +-
4 64 M HCV +-
5 27 M Cholestasis ++ +
6 38 F HCV +-
7 45 F HBV/HCV --
8 53 M Suspicious for neoplasia ++ +
9 51 F Surrounding of FNH +++ ++
10 46 F Surrounding of adenoma ++ +
11 38 M HCV +-
Table 2. Clinical and immunohistochemical data regarding 25 liver samples obtained at autopsy, all characterized at histology by absent
or minimal changes. + = weak and focal; ++ = weak and diffuse; +++ = strong and diffuse.
Case n.  Age Sex Clinical diagnosis Grade of Tß4 immunostaining Zone 3 Grade of Tß4 immunostaining Zone 1
1 83 M Heart attack +++ ++
2 59 M Heart attack +++ ++
3 62 F Cardiac Infarction  ++ +
4 60 M Pneumonia ++   +
5 43 M Heart attack ++ +
6 73 F Heart attack ++ ++
7 31 M ++ +
8 32 M Pulmonary embolism ++ +
9 68 F Heart attack +/- -
10 50 M+ -
11 45 F Haemopericardium ++
12 91 F Heart attack ++ +
13 81 M Aortic aneurism +++ ++
14 58 F Sepsis ++ +
15 71 F Respiratory insufficiency  ++ +
16 49 M Heart attack +++ ++
17 61 M Pulmonary embolism ++ +
18 53 M Heart rupture +-
19 78 M Brain haemorrage ++ +
20 67 F Pulmonary embolism ++ +
21 80 F Brain haemorrage ++ -
22 47 M Pneumonia ++ +
23 75 M Intestinal infarct ++ +
24 53 F Post-haemorragic shock ++ +
25 49 M Heart attack ++ +[European Journal of Histochemistry 2011; 55:e25] [page 133]
immunostaining and age or sex of the sub-
jects.  Immunoreactivity  for  the  peptide  was
mainly localized in the cytoplasm of hepato-
cytes, appearing as large granules different in
shape and size. At low power, in the vast major-
ity of cases, immunoreactivity for Tʲ4 was not
homogeneously diffuse to the entire parenchy-
ma: it was mainly stored in periterminal hepa-
tocytes (zone 3 of the acinus) while a minor
degree of reactivity was detected in periportal
hepatocytes  (zone  1)  (Figure  1).  We  often
detected a zonation of Tʲ4 expression, charac-
terized by a progressive increase in the degree
of immunostaining from the periportal to the
periterminal areas, intermediate levels of Tʲ4
immunostaining being observed in the hepato-
cytes  of  acinar  zone  2.  In  some  cases  (see
Table 1 and Table 2), the periportal hepatocytes
did not show any reactivity for the peptide: in
these cases, only a mild reactivity for the pep-
tide was found in zone 3 liver cells, indicating
a strict correlation between Tʲ4 storage in the
different acinar zones. The degree of reactivi-
ty changed from one case to the next. In some
cases only the periterminal hepatocytes were
reactive for the peptide (Figure 2), while in
other cases even periportal hepatocytes were
immunostained (Figure 3). Tʲ4-reactive intra-
cytoplasmic  granules  appeared  mainly  local-
ized at the biliary pole of hepatocytes (Figure
4).  In  cases  with  a  strong  immunostaining,
even perinuclear areas and the sinusoidal pole
of  hepatocytes  appeared  interested  by  Tʲ4
overload (Figure 5). Even the size of Tʲ4 gran-
ules changed from one case to the next, the
largest  immunoreactive  granules  constantly
being observed in cases characterized by the
highest  levels  of  reactivity  for  the  peptide
(Figure 5). The vast majority of stored peptide
was constantly found inside the cytoplasm of
the hepatocytes, in the absence of significant
Tʲ4 staining in Kupffer cells and in Ito cells. 
Discussion
For some decades from the discovery of Tʲ4
in the calf thymus in 1965,22 researchers have
looked at its distribution in different organs
and tissues and asked, what does it mean? To
date, the majority of attempts to elucidate the
mechanism of action of Tʲ4 in living organ-
isms has come from the perspective of physiol-
ogists, biochemists and biologists and, possi-
bly, have lacked an understanding of the role
played by this peptide in human health and
disease. 
To this date, at the best of our knowledge,
only one study from our group has investigated
Tʲ4  expression  in  the  human  liver  in  new-
borns and during foetal development.21 In that
study, Tʲ4 was not detected in liver cells, in
hepatocytes, in ductal cells and in oval cells of
the ductal plate, whereas low levels of expres-
sion  were  occasionally  detected  in  isolated
cells  inside  the  loose  connective  tissue  of
immature  portal  tracts.  These  data  were  in
favour of a minor role of human liver in Tʲ4
metabolism. On the contrary, the current work
evidences  striking  differences  between  the
adult human liver and the newborn liver as for
Tʲ4 immunoreactivity. The two conditions, the
newborn and the adult, appear to represent the
extremes of a spectrum: complete absence of
the peptide in liver cells at birth, and a strong
diffuse  accumulation  in  the  hepatocytes  in
some adults. 
It  is  unclear  why  this  difference  in  the
amount of Tʲ4 exists between adults and new-
borns,  but  our  findings  confirm  previous
reports on the ability of Tʲ4, as well of other
beta-thymosins, to change its expression dur-
ing life, both quantitatively and qualitatively.
In human salivary glands, we first showed a
decrease in the degree of Tʲ4 expression from
the  foetus  and  the  newborn  to  adults.23
Moreover, we also showed a modification of
the  protein  expression  pattern,  which  was
granular and mainly localized inside the acinar
lumen in newborns, while it appeared homoge-
neously  diffuse  to  the  entire  cytoplasm  in
adults.23 The granular reactivity was interpret-
ed as a secretory pattern, explaining the previ-
ously reported presence of large amounts of
Tʲ4 in saliva of newborns;7 the weak homoge-
neous  staining  of  the  entire  cytoplasm  was
interpreted as a structural pattern, putatively
related  to  the  G-actin  binding  activity  of
Tʲ4.2,20 The present study adds strenght to a
marked variability in the expression and func-
tion of Tʲ4 in different organs, showing a com-
pletely  opposite  modification  in  the  peptide
expression in the liver, characterized by the
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Figure 2. A strong Tʲ4-imunoreactivity is
observed in the periterminal hepatocytes.
Scale bar: 400 µm.
Figure 3. A lower Tʲ4-immunoreactivity is
detected  in  periportal  hepatocytes.  Scale
bar: 400 µm.
Figure  4.  Tʲ4-reactive  intracytoplasmic
granules are localized at the biliary pole of
hepatocytes. Scale bar: 400 µm.
Figure 5. Tʲ4-reactive granules with a per-
inuclear distribution in the hepatocytes are
detected.  Tʲ4  immunoreactivity  at  the
sinusoidal  pole  of  the  cytoplasm  of  the
hepatocytes is observed. Scale bar: 400 µm.
Figure 1. Tʲ4 immunoreactivity is local-
ized  in  the  periterminal  hepatocytes.  A
minor reactivity for the peptide is detected
in  the  periportal  hepatocytes.  Scale  bar:
250 µm.[page 134] [European Journal of Histochemistry 2011; 55:e25]
absence of Tʲ4 at birth and its impressive syn-
thesis in the adult.
The high intracellular concentration of Tʲ4
observed in normal hepatocytes deserves some
consideration on the not well known activity of
this versatile peptide. The main intracellular
action of ʲ-thymosins in resting cells has gen-
erally  been  considered  their  ability  to
sequester monomeric actin, inhibiting its abil-
ity  to  polymerize  and  therefore  removing  it
from the cycling actin pool.24 During cell acti-
vation  for  cellular  activities  like  locomotion,
actin monomers are rapidly desequestrated in
order to achieve the formation of actin fila-
ments.2 As  a  consequence,  the  intracellular
concentration of Tʲ4 has been found to be par-
ticularly high in cells that rapidly respond to
external  signals  by  profound  shape  changes
like platelets25,26 or by increased motility like
polymorphonuclear cells,27 mast cells5 and ma-
crophages.28,29 The observation in this study of
large amounts of Tʲ4 in the hepatocytes, i.e. in
cells which do not rapidly change their shape
or their motility, clearly supports the hypothe-
sis that Tʲ4 is not a simple actin monomer
binding  protein.3 The  massive  hepatic  Tʲ4
expression  described  in  this  study  in  some
subjects, adds hepatocytes to the list of human
cells able to sinthesize large amounts of the
peptide in adulthood. The serum concentration
of free Tʲ4 has been estimated to range from
0.45 up to 1.1 ʼg/L,6 which is very high when
compared  to  the  concentration  of  insulin  or
glucagon,2 but  comparable  to  the  adenosin
concentration.30 Such an high serum level of
Tʲ4 in the steady state can not be explained by
its release by platelets during blood coagula-
tion24 or by leukocytes and monocytes during
inflammation.31 On the contrary, the present
work  induces  to  hypothesize  that  the  high
serum content of Tʲ4 could, at least in part,
originate by hepatocytes. Further studies cor-
relating  the  hepatic  Tʲ4  expression  pattern
with serum levels of the peptide will clarify the
role of liver cells in plasma Tʲ4 levels. 
The preferential concentration of Tʲ4 in the
hepatocytes of zone 3 of the liver acinus also
deserves some consideration. The descending
gradient from the terminal vein towards the
periportal  areas  indicate  that  the  peptide  is
mainly synthesized in zone 3 hepatocytes and,
only when major quantities of Tʲ4 are needed,
even  zone  2  and  zone  1  hepatocytes  are
recruited for its additional synthesis. A similar
zonation pattern, with high expression in the
downstream  perivenous  region,  has  ben
described for many liver enzymes, including
Cytochrome  P-45032 and  glutamine  syn-
thetase.33 By comparison with our knowledge
on the acinar gradients of liver proteins, now
including Tʲ4, much less is known about how
these  gradients  are  formed,  modified  and
maintained. Different concentrations of oxy-
gen and of humoral factors have been proposed
to  may  create  a  gradient-type  zonation  pat-
tern.32 In recent years, a fundamental role in
mechanisms  involved  in  patterning  of  liver
parenchyma  has  been  attributed  to  mor-
phogens, including Wnt, ʲ-catenin, and adeno-
matous polyposis coli gene.33 As for the gradi-
ent-type  zonation  observed  in  this  study  for
Tʲ4, our data show a marked interindividual
variability, not only in the degree of expression
but even in the zonation pattern. This finding
suggests that the intensity of Tʲ4 synthesis
and the slope of the gradient can vary. Diurnal
variations in the degree and in spatial expres-
sion  have  been  reported  for  other  liver
enzymes, including CYP7.34 The low levels of
Tʲ4 expression in all liver biopsies from sub-
jects positive for HBV or HCV markers (Table
1) induces to hypothesize a possible role for
hepatitis-related  viruses  in  down-regulating
Tʲ4 synthesis in infected liver cells. 
In conclusion, interesting data emerge from
the analysis of Tʲ4 expression in liver cells,
clearly indicating Tʲ4 as one of the proteins
synthesized by hepatocytes in normal condi-
tions. Identifying the intimate role played by
this peptide intracellularly and extracellularly,
in physiology and in liver diseases, is a major
challenge for future research focusing on Tʲ4
expression in the human liver in health and
disease.
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